期刊文献+

Endoscopic foregut surgery and interventions:The future is now.The state-of-the-art and my personal journey 被引量:9

Endoscopic foregut surgery and interventions:The future is now.The state-of-the-art and my personal journey
下载PDF
导出
摘要 In this paper, I reviewed the emerging field of endoscopic surgery and present data supporting the contention that endoscopy can now be used to treat many foregut diseases that have been traditionally treated surgically. Within each topic,the content will progress as follows: "lessons learned", "technical considerations"and "future opportunities". Lessons learned will provide a brief background and update on the most current literature. Technical considerations will include my personal experience, including tips and tricks that I have learned over the years.Finally, future opportunities will address current unmet needs and potential new areas of development. The foregut is defined as "the upper part of the embryonic alimentary canal from which the pharynx, esophagus, lung, stomach, liver,pancreas, and part of the duodenum develop". Foregut surgery is well established in treating conditions such as gastroesophageal reflux disease(GERD), achalasia, esophageal diverticula, Barrett's esophagus(BE) and esophageal cancer, stomach cancer, gastric-outlet obstruction, and obesity. Over the past decade, remarkable progress in interventional endoscopy has culminated in the conceptualization and practice of endoscopic foregut surgery for various clinical conditions summarized in this paper. Regarding GERD, there are now several technologies available to effectively treat it and potentially eliminate symptoms, and the need for long-term treatment with proton pump inhibitors.For the first time, fundoplication can be performed without the need for open or laparoscopic surgery. Long-term data going out 5-10 years are now emerging showing extended durability. In respect to achalasia, per-oral endoscopic myotomy(POEM) which was developed in Japan, has become an alternative to the traditional Heller's myotomy. Recent meta-analysis show that POEM may have better results than Heller, but the issue of post-POEM GERD still needs to be addressed. There is now a resurgence of endoscopic treatment of Zenker's diverticula with improved tec In this paper, I reviewed the emerging field of endoscopic surgery and present data supporting the contention that endoscopy can now be used to treat many foregut diseases that have been traditionally treated surgically. Within each topic,the content will progress as follows: "lessons learned", "technical considerations"and "future opportunities". Lessons learned will provide a brief background and update on the most current literature. Technical considerations will include my personal experience, including tips and tricks that I have learned over the years.Finally, future opportunities will address current unmet needs and potential new areas of development. The foregut is defined as "the upper part of the embryonic alimentary canal from which the pharynx, esophagus, lung, stomach, liver,pancreas, and part of the duodenum develop". Foregut surgery is well established in treating conditions such as gastroesophageal reflux disease(GERD), achalasia, esophageal diverticula, Barrett's esophagus(BE) and esophageal cancer, stomach cancer, gastric-outlet obstruction, and obesity. Over the past decade, remarkable progress in interventional endoscopy has culminated in the conceptualization and practice of endoscopic foregut surgery for various clinical conditions summarized in this paper. Regarding GERD, there are now several technologies available to effectively treat it and potentially eliminate symptoms, and the need for long-term treatment with proton pump inhibitors.For the first time, fundoplication can be performed without the need for open or laparoscopic surgery. Long-term data going out 5-10 years are now emerging showing extended durability. In respect to achalasia, per-oral endoscopic myotomy(POEM) which was developed in Japan, has become an alternative to the traditional Heller's myotomy. Recent meta-analysis show that POEM may have better results than Heller, but the issue of post-POEM GERD still needs to be addressed. There is now a resurgence of endoscopic treatment of Zenker's diverticula with improved tec
出处 《World Journal of Gastroenterology》 SCIE CAS 2019年第1期1-41,共41页 世界胃肠病学杂志(英文版)
关键词 Endoscopy FOREGUT diseases GASTROESOPHAGEAL reflux disease ENDOSCOPIC sleeve GASTROPLASTY ENDOSCOPIC submucosal dissection Per-oral ENDOSCOPIC MYOTOMY Endo-hepatology Endoscopy Foregut diseases Gastroesophageal reflux disease Endoscopic sleeve gastroplasty Endoscopic submucosal dissection Per-oral endoscopic myotomy Endo-hepatology
  • 相关文献

二级参考文献12

  • 1Young Dae Kim,Jun Lee,Ju Yeon Cho,Seok Won Kim,Seong Hwan Kim,Young Kwan Cho,Jin Seok Jang,Ji Sun Han,Joo Young Cho.Efficacy and safety of 0.4 percent sodium hyaluronate for endoscopic submucosal dissection of gastric neoplasms[J].World Journal of Gastroenterology,2013,19(20):3069-3076. 被引量:26
  • 2Anne F. Peery,Evan S. Dellon,Jennifer Lund,Seth D. Crockett,Christopher E. McGowan,William J. Bulsiewicz,Lisa M. Gangarosa,Michelle T. Thiny,Karyn Stizenberg,Douglas R. Morgan,Yehuda Ringel,Hannah P. Kim,Marco Dacosta DiBonaventura,Charlotte F. Carroll,Jeffery K. Allen,Suzanne F. Cook,Robert S. Sandler,Michael D. Kappelman,Nicholas J. Shaheen.Burden of Gastrointestinal Disease in the United States: 2012 Update[J].Gastroenterology.2012(5) 被引量:15
  • 3Peter J Kahrilas,Guy Boeckxstaens.Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?[J].Gut.2012(10) 被引量:1
  • 4Tiberiu Hershcovici,Ronnie Fass.An algorithm for diagnosis and treatment of refractory GERD[J].Best Practice & Research Clinical Gastroenterology.2010(6) 被引量:1
  • 5Ayman M. Abdel Aziz,Hisham R. El-Khayat,Ahmed Sadek,Samer G. Mattar,Gail McNulty,Pradermchai Kongkam,Mohamed F. Guda,Glen A. Lehman.A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease[J].Surgical Endoscopy.2010(4) 被引量:1
  • 6Bonnie B. Dean,Anacleto D. Gano,Kevin Knight,Joshua J. Ofman,Ronnie Fass.Effectiveness of proton pump inhibitors in nonerosive reflux disease[J].Clinical Gastroenterology and Hepatology.2004(8) 被引量:2
  • 7Douglas A. Corley,Philip Katz,John M. Wo,Andreas Stefan,Marco Patti,Richard Rothstein,Steven Edmundowicz,Michael Kline,Rodney Mason,M.Michael Wolfe.Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial[J].Gastroenterology.2003(3) 被引量:1
  • 8George Triadafilopoulos.Stretta: an effective, minimally invasive treatment for gastroesophageal reflux disease[J].The American Journal of Medicine.2003(3) 被引量:1
  • 9George Triadafilopoulos,John K. DiBaise,Timothy T. Nostrant,Neil H. Stollman,Paul K. Anderson,M.Michael Wolfe,Richard I. Rothstein,John M. Wo,Douglas A. Corley,Marco G. Patti,Louis V. Antignano,John S. Goff,Steven A. Edmundowicz,Donald O. Castell,John C. Rabine,Michael S. Kim,David S. Utley.The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial[J].Gastrointestinal Endoscopy.2002(2) 被引量:1
  • 10Hai—Feng Liu Jian-Guo Zhang Jun Li Xiao-Guang Chen Wei-An Wang.Improvement of clinical parameters in patients with gastroesophageal reflux disease after radiofrequency energy delivery[J].World Journal of Gastroenterology,2011,17(39):4429-4433. 被引量:9

共引文献26

同被引文献51

引证文献9

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部